Genomic structure, expression pattern, and chromosomal localization of the human calsenilin gene: No association between an exonic polymorphism and Alzheimer's disease

Joseph D. Buxbaum, Christina Lilliehook, Joseph Y. Chan, Rodney C.P. Go, Susan S. Bassett, Rudolph E. Tanzi, Wilma Wasco, Deborah Blacker

Research output: Contribution to journalArticle

Abstract

Calsenilin is a recently-identified member of the neuronal calcium sensor family. Like other members of this family, it is found in the brain and binds calcium. Calsenilin was discovered by virtue of its interaction with both presenilin-1 and -2, proteins that are involved in the etiology of Alzheimer's disease. Because calsenilin may play a role in Alzheimer's disease and other disease with alterations in calcium homeostasis, we characterized the human gene. The gene, which we localized to chromosome 2, extends over a region of at least 74 kb and includes nine exons. Interestingly, the ninth exon of calsenilin contains a highly polymorphic CA repeat, adjacent to the stop codon. In a study of Alzheimer patients and their unaffected siblings, there was no evidence of association of AD with any calsenilin allele. This CA repeat will be useful for linkage and linkage disequilibrium studies to determine whether calsenilin variants contribute to risk in other diseases. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)135-138
Number of pages4
JournalNeuroscience Letters
Volume294
Issue number3
DOIs
StatePublished - Nov 24 2000

    Fingerprint

Keywords

  • Alzheimer's disease
  • Calsenilin gene
  • Presenilin-1 and -2

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this